Pumaprazole, formerly known as BY-841, is a potent, selective and reversible proton pump antagonist. Both before and after cure of H. pylori infection, pumaprazole raised the intragastric pH over a 24-h period to a similar degree as omeprazole. H. pylori infection similarly augments the pH-increasing effect of both drugs. This effect is related to H. pylori infection and not to an increased activation of acid inhibitory agents in the parietal cell compartment. References: Kromer W, Postius S, Riedel R. Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles. Pharmacology. 2000 May;60(4):179-87. PubMed PMID: 10828742.

纯度：≥98%

CAS：158364-59-1